Showing 19,861 - 19,880 results of 96,767 for search '(( i we decrease ) OR ( 50 ((((teer decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.76s Refine Results
  1. 19861
  2. 19862

    The Response of the Alpine Dwarf Shrub <i>Salix herbacea</i> to Altered Snowmelt Timing: Lessons from a Multi-Site Transplant Experiment by Janosch Sedlacek (301844)

    Published 2015
    “…We tested how the common, long-lived dwarf shrub <i>Salix herbacea</i> responded to changing spring snowmelt time by reciprocally transplanting turfs of <i>S</i>. …”
  3. 19863

    Image_2_Restored CD8+PD-1+ T Cells Facilitate the Response to Anti-PD-1 for Patients With Pancreatic Ductal Adenocarcinoma.jpeg by Qian Zhu (191342)

    Published 2022
    “…The peripheral blood T lymphocyte subtypes were tracked for 30 months, and CD8<sup>+</sup>PD-1<sup>+</sup> cells were shown to decrease. After that, we performed ACT for patients with APC in another cancer center. …”
  4. 19864

    p53 Target Gene SMAR1 Is Dysregulated in Breast Cancer: Its Role in Cancer Cell Migration and Invasion by Kamini Singh (32638)

    Published 2007
    “…We show that SMAR1 transcription is regulated by p53 through its response element present in the SMAR1 promoter. …”
  5. 19865

    Trends in the risk of myocardial infarction among HIV-1-infected individuals relative to the general population in France: Impact of gender and immune status by Aliou Baldé (6236762)

    Published 2019
    “…<div><p>We examined trends in the MI incidence and age at MI diagnosis among adults living with HIV-1 between 2000 and 2009, by comparison with the French MI registries, by gender. …”
  6. 19866

    Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for <i>In Vivo</i> Mouse Studies by Mickael Fer (18945964)

    Published 2024
    “…We discovered two new GPR88 agonists: One that reduced morphine-induced locomotor activity in a murine proof-of-concept study, and the atropoisomeric BI-9508, which is a brain penetrant and has improved pharmacokinetic properties and dosing that recommend it for future <i>in vivo</i> studies in rodents. …”
  7. 19867

    Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for <i>In Vivo</i> Mouse Studies by Mickael Fer (18945964)

    Published 2024
    “…We discovered two new GPR88 agonists: One that reduced morphine-induced locomotor activity in a murine proof-of-concept study, and the atropoisomeric BI-9508, which is a brain penetrant and has improved pharmacokinetic properties and dosing that recommend it for future <i>in vivo</i> studies in rodents. …”
  8. 19868

    Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for <i>In Vivo</i> Mouse Studies by Mickael Fer (18945964)

    Published 2024
    “…We discovered two new GPR88 agonists: One that reduced morphine-induced locomotor activity in a murine proof-of-concept study, and the atropoisomeric BI-9508, which is a brain penetrant and has improved pharmacokinetic properties and dosing that recommend it for future <i>in vivo</i> studies in rodents. …”
  9. 19869

    Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for <i>In Vivo</i> Mouse Studies by Mickael Fer (18945964)

    Published 2024
    “…We discovered two new GPR88 agonists: One that reduced morphine-induced locomotor activity in a murine proof-of-concept study, and the atropoisomeric BI-9508, which is a brain penetrant and has improved pharmacokinetic properties and dosing that recommend it for future <i>in vivo</i> studies in rodents. …”
  10. 19870

    Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for <i>In Vivo</i> Mouse Studies by Mickael Fer (18945964)

    Published 2024
    “…We discovered two new GPR88 agonists: One that reduced morphine-induced locomotor activity in a murine proof-of-concept study, and the atropoisomeric BI-9508, which is a brain penetrant and has improved pharmacokinetic properties and dosing that recommend it for future <i>in vivo</i> studies in rodents. …”
  11. 19871

    Discovery of BI-9508, a Brain-Penetrant GPR88-Receptor-Agonist Tool Compound for <i>In Vivo</i> Mouse Studies by Mickael Fer (18945964)

    Published 2024
    “…We discovered two new GPR88 agonists: One that reduced morphine-induced locomotor activity in a murine proof-of-concept study, and the atropoisomeric BI-9508, which is a brain penetrant and has improved pharmacokinetic properties and dosing that recommend it for future <i>in vivo</i> studies in rodents. …”
  12. 19872

    Geometrical Constraints Greatly Hinder Formin mDia1 Activity by Emiko L. Suzuki (8124296)

    Published 2019
    “…Combining microfluidics and micropatterning, we reconstituted in vitro mDia1 formin-elongated filament bundles induced by fascin, with different geometrical constraints on the formins, and measured the impact of these constraints on formin elongation rate and processivity. …”
  13. 19873

    Geometrical Constraints Greatly Hinder Formin mDia1 Activity by Emiko L. Suzuki (8124296)

    Published 2019
    “…Combining microfluidics and micropatterning, we reconstituted in vitro mDia1 formin-elongated filament bundles induced by fascin, with different geometrical constraints on the formins, and measured the impact of these constraints on formin elongation rate and processivity. …”
  14. 19874

    Geometrical Constraints Greatly Hinder Formin mDia1 Activity by Emiko L. Suzuki (8124296)

    Published 2019
    “…Combining microfluidics and micropatterning, we reconstituted in vitro mDia1 formin-elongated filament bundles induced by fascin, with different geometrical constraints on the formins, and measured the impact of these constraints on formin elongation rate and processivity. …”
  15. 19875

    Geometrical Constraints Greatly Hinder Formin mDia1 Activity by Emiko L. Suzuki (8124296)

    Published 2019
    “…Combining microfluidics and micropatterning, we reconstituted in vitro mDia1 formin-elongated filament bundles induced by fascin, with different geometrical constraints on the formins, and measured the impact of these constraints on formin elongation rate and processivity. …”
  16. 19876

    Regulatory Protein OmpR Influences the Serum Resistance of <i>Yersinia enterocolitica</i> O:9 by Modifying the Structure of the Outer Membrane by Karolina Skorek (487088)

    Published 2013
    “…We propose that OmpR might alter the susceptibility of <i>Y. enterocolitica</i> O:9 to complement-mediated killing through remodeling of the outer membrane.…”
  17. 19877

    Integrating Paleodistribution Models and Phylogeography in the Grass-Cutting Ant <i>Acromyrmex striatus</i> (Hymenoptera: Formicidae) in Southern Lowlands of South America by Maykon Passos Cristiano (392173)

    Published 2016
    “…From the partial sequences of the mitochondrial gene cytochrome oxidase I of 128 <i>A</i>. <i>striatus</i> workers from 38 locations we estimated genetic diversity and inferred historical demography, divergence time, and population structure. …”
  18. 19878

    Supplementary Table 3 from <i>Pendraig milnerae</i>, a new small-sized coelophysoid theropod from the Late Triassic of Wales by Stephan N. F. Spiekman (11519370)

    Published 2021
    “…We describe a new small-bodied coelophysoid theropod dinosaur, <i>Pendraig milnerae</i> gen. et sp. nov, from the Late Triassic fissure fill deposits of Pant-y-ffynnon in southern Wales. …”
  19. 19879

    DataSheet1_Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids.docx by Mohamed Elbadawy (15317848)

    Published 2023
    “…Treatment of NLO with a DPR1 inhibitor, Mdivi-1 resulted in the improvement of morphology and the decreased expression of fibrosis-related markers, Col1a1 and Acta2. …”
  20. 19880

    DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway by Tingting Pan (4735617)

    Published 2022
    “…In addition, we found that MEG3 expression was negatively correlated with DNMT1. …”